ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

ClinicalTrials.gov ID: NCT06270836

Public ClinicalTrials.gov record NCT06270836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-masked, Sham-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer in Participants With Diabetic Retinopathy (DR) - GLOW2

Study identification

NCT ID
NCT06270836
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kodiak Sciences Inc
Industry
Enrollment
255 participants

Conditions and interventions

Interventions

  • Sham injection Other
  • Tarcocimab Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2024
Primary completion
Feb 12, 2026
Completion
Feb 12, 2026
Last update posted
May 12, 2026

2024 – 2026

United States locations

U.S. sites
38
U.S. states
18
U.S. cities
37
Facility City State ZIP Site status
Retina Associates SW Tucson Arizona 85704
Retina Consultants of Orange County Fullerton California 92835
Global Research Management, Inc. - Lugene Eye Institute Glendale California 91204
Retinal Consultants Medical Group, Inc. Modesto California 95356
Retina Consultants of Southern California Redlands California 92374
Retinal Consultants Medical Group, Inc. Sacramento California 95825
Retina Group of New England, PC Waterford Connecticut 06385
Retina Group of Florida Fort Lauderdale Florida 33308
Florida Eye Associates Melbourne Florida 32901
Center for Retina and Macular Disease Winter Haven Florida 33880
Southeast Retina Center Augusta Georgia 30909
Springfield Clinic LLP Springfield Illinois 62703
Associated Vitreoretinal and Uveitis Consultants Carmel Indiana 46290
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Retina Consultants of Nevada Henderson Nevada 89052
Envision Ocular, LLC Bloomfield New Jersey 07003
Asheville Eye Associates Asheville North Carolina 28803
North Carolina Retina Associates (Cary) Cary North Carolina 27511
North Carolina Retina Associates (Wake Forest) Wake Forest North Carolina 27587
Cascade Medical Research Institute Springfield Oregon 97477
Erie Retina Research Erie Pennsylvania 16507
Charleston Neuroscience Institute Charleston South Carolina 29414
Charles Retina Institute Germantown Tennessee 38138
Southeastern Retina Associates PC Knoxville Tennessee 37922
Retina Research Institute of Texas Abilene Texas 79606
Panhandle Eye Group, LLP. - Southwest Retina Specialists Amarillo Texas 79106
Austin Retina Associates, PLLC (Austin) Austin Texas 78705-1169
Austin Research Center for Retina Austin Texas 78705
Retina Consultants of Texas (Bellaire) Bellaire Texas 77401
Star Vision Research Burleson Texas 76028
Retina Consultants of Texas (Katy) Katy Texas 77494
Texas Retina Associates Plano Texas 75075
Austin Retina Associates, PLLC (Round Rock) Round Rock Texas 78681
Retina Consultants of Texas (San Antonio) San Antonio Texas 78240
Retina Consultants of Texas (Woodlands) The Woodlands Texas 77384
Piedmont Eye Center Lynchburg Virginia 24502
Pacific Northwest Retina (Bellevue) Bellevue Washington 98004
Spokane Eye Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06270836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06270836 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →